Bladder Cancer: Clinical Trials

16 trials for Bladder Cancer, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 6 unknown, 2 withdrawn, 1 not yet recruiting. 16 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 416Completed 6, Unknown 6, Withdrawn 2, Not yet recruiting 1, Recruiting 1

Follow Bladder Cancer: new trials by email Literature Review of Bladder Cancer trials Research Report on Bladder Cancer

Trials (filtered) newest first · largest first

All 16 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Impact of PDD During TURB for NMIBC
Transurethral resection of the bladder performed with PDD tecnique and Hexvix - Bladder Cancer
Phase 4Not yet recruitingA.O.U. Città della Salute e della Scienza3002024-09-012024-08-12
A Trial to Evaluate Efficacy of Reinduction With Nadofaragene Firadenovec in Subjects With CIS ± High-grade Ta/T1 and no Complete Response to First Nadofaragene Firadenovec Dose.
nadofaragene firadenovec - Bladder Cancer, Ta/T1
Phase 4WithdrawnFerring Pharmaceuticals2024-06-172024-11-22
A Clinical Study of Disitamab Vedotin for Injection Combined With Penpulimab Injection in Neoadjuvant Therapy for Patients With HER2-expressing Cisplatin-intolerant cT2-T4aNxM0 Bladder Urothelial Carcinoma
Disitamab Vedotin for Injection,Penpulimab Injection - Bladder Cancer
Phase 4UnknownSun Yat-Sen Memorial Hospital of Sun Yat-Sen University482022-09-012022-08-04
Impact of Remimazolam on Prognosis After Bladder Cancer Surgery
Remimazolam, Propofol - Benzodiazepines, Bladder Cancer
Phase 4RecruitingPeking University First Hospital11282021-02-052025-07-30
Sequential Combination Therapy in Bladder Cancer
Mitomycin - Bladder Cancer
Phase 4UnknownAzienda Ospedaliera "Sant'Andrea"1402019-01-152018-12-31
The Effect of Preemptive Analgesia On The Comfort Of Patient and Doctor, in Cystoscopy
Diclofenac Sodium, Cystoscopy, Lubricant Gel - Bladder Cancer, Benign Prostate Hyperplasia
Phase 4UnknownTaha Uçar1442018-12-112019-02-05
Neoadjuvant Short-term Intensive Chemoresection Versus Standard Adjuvant Intravesical Instillations in NMIBC
Mitomycin c - Bladder Cancer
Phase 4CompletedJørgen Bjerggaard Jensen1202017-11-012026-03-03
Chemoradiotherapy for Recurrent T1G3 Bladder Cancer
chemoradiation - Bladder Cancer
Phase 4UnknownAssiut University202017-10-012017-09-11
Investigation of Sugammadex in Outpatient Urological Procedures
Rocuronium, Sugammadex, Neostigmine - Malignant Neoplasms of Urinary Tract, Bladder Cancer
Phase 4CompletedM.D. Anderson Cancer Center542017-09-182020-09-22
Mebeverine For 1st Year Daytime And Nocturnal Incontinence After Orthotopic W-Ileal Neobladders
Coloverin, Placebo - Oncology, Incontinence
Phase 4CompletedMansoura University1102017-05-152020-06-30
Influence of Immune Nutrition Diet on 90-Day Outcomes in Patients Undergoing Radical Cystectomy
Bio-tech and omega-3 plus, placebo - Bladder Cancer, Oncology
Phase 4UnknownMansoura University1002017-03-012017-05-10
Comparison of Medical and Surgical Treatments of Benign Prostate Hyperplasia in Patients Who Have Low Grade Non Muscle Invasive Bladder Cancer for Tumour Recurrence and Progression
Transurethral Resection, Tamsulosin - Bladder Cancer
Phase 4UnknownDiskapi Teaching and Research Hospital402015-02-012015-05-14
Recurrence of Bladder Cancer After Transurethral Resection With Hexvix
hexaminolevulinate - Bladder Cancer
Phase 4WithdrawnGE Healthcare2008-12-012015-04-24
Health Education Counseling With or Without Bupropion in Helping African Americans Stop Smoking
smoking cessation intervention, bupropion hydrochloride, gene expression analysis - Bladder Cancer, Cervical Cancer
Phase 4CompletedLisa Sanderson Cox, PhD5402007-12-012017-11-13
In the Prediction of Recurrence and Progression of NMIBC; EORTC or CUETO or Both?
Intravesical BCG instillation - Bladder Cancer, Disease Progression
Phase 4CompletedAnkara Training and Research Hospital4002007-01-012017-06-05
Counseling and Nicotine Replacement Therapy in Helping Adult Smokers Quit Smoking
nicotine lozenge, nicotine patch - Bladder Cancer, Cervical Cancer
Phase 4CompletedFox Chase Cancer Center6422006-02-012016-03-29

Narrower conditions

Urinary Bladder Neoplasms (16)  ·  Carcinoma, Hepatocellular (2)  ·  Carcinoma, Non-Small-Cell Lung (2)  ·  Carcinoma, Renal Cell (2)  ·  Disease Progression (2)  ·  Esophageal Neoplasms (2)  ·  Head and Neck Neoplasms (2)  ·  Hypopharyngeal Neoplasms (2)  ·  Kidney Neoplasms (2)  ·  Laryngeal Neoplasms (2)  ·  Leukemia (2)  ·  Leukemia, Myeloid, Acute (2)  ·  Liver Neoplasms (2)  ·  Lung Neoplasms (2)  ·  Mouth Neoplasms (2)

Broader conditions

Female Urogenital Diseases (16)  ·  Female Urogenital Diseases and Pregnancy Complications (16)  ·  Male Urogenital Diseases (16)  ·  Neoplasms by Site (16)  ·  Urinary Bladder Diseases (16)  ·  Urogenital Diseases (16)  ·  Urogenital Neoplasms (16)  ·  Urologic Diseases (16)  ·  Urologic Neoplasms (15)  ·  Neoplasms (14)  ·  Mental Disorders (4)  ·  Pathologic Processes (4)  ·  Pathological Conditions, Signs and Symptoms (4)  ·  Genital Diseases (3)  ·  Adenocarcinoma (2)

Interventions

5-aminolevulinic acid hexyl ester (2)  ·  Mitomycin (2)  ·  BCG Vaccine (1)  ·  Bupropion (1)  ·  Chemoradiotherapy (1)  ·  Counseling (1)  ·  Cystoscopy (1)  ·  Diclofenac (1)  ·  Docosahexaenoic Acids (1)  ·  Early Intervention, Educational (1)  ·  Gene Expression Profiling (1)  ·  Glycopyrrolate (1)  ·  Injections (1)  ·  Neostigmine (1)  ·  Polymerase Chain Reaction (1)

Sponsors

Mansoura University (2)  ·  A.O.U. Città della Salute e della Scienza (1)  ·  Ankara Training and Research Hospital (1)  ·  Assiut University (1)  ·  Azienda Ospedaliera "Sant'Andrea" (1)  ·  Diskapi Teaching and Research Hospital (1)  ·  Ferring Pharmaceuticals (1)  ·  Fox Chase Cancer Center (1)  ·  GE Healthcare (1)  ·  Jørgen Bjerggaard Jensen (1)  ·  Lisa Sanderson Cox, PhD (1)  ·  M.D. Anderson Cancer Center (1)  ·  Peking University First Hospital (1)  ·  Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University (1)  ·  Taha Uçar (1)

Countries

United States (4)  ·  Egypt (2)  ·  Turkey (Türkiye) (2)  ·  China (1)  ·  Denmark (1)  ·  France (1)

Top investigators

Ahmed Mosbah, MD (2)  ·  Abdelwahab R. Hashem, Msc (1)  ·  Ahmed Elhussein, MBBCH (1)  ·  Ahmed Elkarta, MBBCH (1)  ·  Ahmed Harraz, MD (1)  ·  Ahmed Moeen (1)  ·  Andrea Tubaro (1)  ·  Atallah A. Shaaban, MD (1)  ·  Farzin Goravanchi, DO (1)  ·  Francesco Soria (1)  ·  Hassan Abo-Elenin, MD (1)  ·  Hassan Abol-Enein, MD (1)  ·  Jean-Paul Antonini (1)

Results publications

PMID 21266057, PMID 21775497, PMID 22241828, PMID 23170127, PMID 23733379, PMID 23759377, PMID 23982601, PMID 33300144, PMID 34611902, PMID 34791718, PMID 36223555, PMID 37230961, PMID 38842053, PMID 39868569

NIH funding

2017 (1), R01CA091912 (1)